【24h】

Development of a novel osmotically driven drug delivery system for weakly basic drugs.

机译:为弱碱性药物开发新型的渗透驱动药物输送系统。

获取原文
获取原文并翻译 | 示例
           

摘要

The drug substance SAG/ZK has a short biological half-life and because of its weakly basic nature a strong pH-dependent solubility was observed. The aim of this study was to develop a controlled release (cr) multiple unit pellet formulation for SAG/ZK with pH-independent drug release. Pellets with a drug load of 60% were prepared by extrusion/spheronization followed by cr-film coating with an extended release polyvinyl acetate/polyvinyl pyrrolidone dispersion (Kollidon SR 30 D). To overcome the problem of pH-dependent drug release the pellets were then coated with a second layer of an enteric methacrylic acid and ethyl acrylate copolymer (Kollicoat MAE 30 DP). To increase the drug release rates from the double layered cr-pellets different osmotically active ionic (sodium and potassium chloride) and nonionic (sucrose) additives were incorporated into the pellet core. Drug release studies were performed in media of different osmotic pressure to clarify the main release mechanism. Extended release coated pellets of SAG/ZK demonstrated pH-dependent drug release. Applying a second enteric coat on top of the extended release film coat failed in order to achieve pH-independent drug release. Already low enteric polymer levels on top of the extended release coated pellets decreased drug release rates at pH 1 drastically, thus resulting in a reversal of the pH-dependency (faster release at pH 6.8 than in 0.1N HCl). The addition of osmotically active ingredients (sodium and potassium chloride, and sucrose) increased the imbibing of aqueous fluids into the pellet cores thus providing a saturated drug solution inside the beads and increasing drug concentration gradients. In addition, for these pellets increased formation of pores and cracks in the polymer coating was observed. Hence drug release rates from double layered beads increased significantly. Therefore, pH-independent osmotically driven SAG/ZK release was achieved from pellets containing osmotically active ingredients and coated with an extended and enteric polymer. In contrast, with increasing osmotic pressure of the dissolution medium the in vitro drug release rates decreased significantly.
机译:药物SAG / ZK具有较短的生物学半衰期,并且由于其弱碱性,可以观察到很强的pH依赖性溶解度。这项研究的目的是开发用于SAG / ZK且具有pH依赖性药物释放的控释(cr)多单位颗粒制剂。通过挤出/滚圆,然后用缓释聚乙酸乙烯酯/聚乙烯吡咯烷酮分散体(Kollidon SR 30 D)进行cr-膜包衣,制备载药量为60%的药丸。为了克服pH依赖性药物释放的问题,然后将丸粒用肠溶性甲基丙烯酸和丙烯酸乙酯共聚物(Kollicoat MAE 30 DP)的第二层包衣。为了增加从双层cr-小丸的药物释放速率,将不同的渗透活性离子(氯化钠和氯化钾)和非离子(蔗糖)添加剂掺入药丸核心中。在不同渗透压的介质中进行了药物释放研究,以阐明主要的释放机理。 SAG / ZK的缓释包衣小丸显示出pH依赖性药物释放。为了实现不依赖于pH的药物释放,在延长释放的薄膜包衣上施加第二层肠溶衣失败。缓释包衣小丸顶部的低肠溶性聚合物水平已经大大降低了pH值为1时的药物释放速率,从而导致了pH依赖性的逆转(在pH 6.8时比在0.1N HCl中释放更快)。渗透活性成分(氯化钠,氯化钾和蔗糖)的添加增加了将水性液体吸收到药丸芯中的作用,从而在药珠内部提供了饱和的药物溶液,并增加了药物浓度梯度。另外,对于这些粒料,观察到聚合物涂层中孔和裂纹的形成增加。因此,双层珠的药物释放速率显着增加。因此,从包含渗透活性成分并用扩展的肠溶性聚合物包衣的小丸中获得了非pH依赖性的渗透压驱动的SAG / ZK释放。相反,随着溶出介质渗透压的增加,体外药物释放速率显着降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号